Market revenue in 2023 | USD 12.8 million |
Market revenue in 2030 | USD 18.1 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | New born screening (nbs) |
Fastest growing segment | CRO/Research |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | New Born Screening (NBS), Infectious Disease Testing, Therapeutic Drug Monitoring, CRO/Research, Other Applications, Forensics |
Key market players worldwide | Qiagen NV, PerkinElmer, Roche Holding AG, Shimadzu Corp, Ahlstrom-Munksjö, Danaher Corp, Centogene NV Ordinary Shares, Eastern Business Forms, Archimedlife |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dried blood spot collection cards market will help companies and investors design strategic landscapes.
New born screening (nbs) was the largest segment with a revenue share of 24.22% in 2024. Horizon Databook has segmented the France dried blood spot collection cards market based on new born screening (nbs), infectious disease testing, therapeutic drug monitoring, cro/research, other applications, forensics covering the revenue growth of each sub-segment from 2018 to 2030.
France accounted for a significant share in Europe market during the forecast period. This share can be attributed to presence of strong healthcare systems, well-established healthcare insurance policies, continuous government support to manage healthcare, and increasing prevalence of infectious diseases, drug abuse, & preterm births.
Respiratory viruses are a major cause of mortality globally. Every year, respiratory viruses cause thousands of deaths during the colder months in France. According to data published by Institut Pasteur, influenza is a public health issue in France as annual seasonal outbreaks affect around 2 to 8 million people every year in the country.
In addition, according to a study published by the European Respiratory Society, in 2018, the prevalence of asthma in France was estimated to be around 6.4%. Such high prevalence and mortality related to respiratory infections are expected to be a major factor boosting the demand for DBS collection cards in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the France dried blood spot collection cards market , including forecasts for subscribers. This country databook contains high-level insights into France dried blood spot collection cards market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account